Chemours Launches Strategic Review of European Materials Business Amidst Declining Demand
On February 18, 2025, Chemours announced a strategic review of its Advanced Performance Materials (APM) business in Europe following the release of its 2024 financial results. This decision comes in response to a 5% decline in net sales, totaling $5.8 billion, primarily driven by a 4% drop in prices and changes in its investment portfolio.
The APM division, which provides products such as fluoropolymers, fluororubbers, and membranes, operates production facilities in Belgium and France. CEO Denise Dignam revealed that Chemours has written down some APM assets and postponed plans to expand Nafion ion exchange material production, crucial for hydrogen generation, due to lower-than-expected market demand projected until 2030.
In addition, Chemours will exit its Surface Protection Solutions (SPS) Capstone business, citing regulatory changes that have decreased demand. Production is set to conclude by the end of Q2 2025, pending local regulatory approvals.
Chemours continues to lead in sectors like thermal and specialty solutions, titanium technologies, and advanced performance materials, providing tailored solutions across various industries, including coatings, plastics, and electronics.
The company’s focus on strategic adjustments reflects its commitment to adapt to market changes while striving to maintain a competitive edge in the evolving materials landscape.
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
WACKER Launches Next-Gen Polysilicon Line in Germany 50 Percent Capacity Boost Targets Semiconductor Demand
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
Jinggong Tech H1 Net Profit Soars 15 Percent Revenue Reaches 1.06 Billion Yuan Carbon Fiber Equipment Drives 59 Percent of Sales
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
Recommend Reading
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
BDO Market Trends Remain in a Limping Consolidation
-
This week, the Aniline market in China showed a strong increase (1.5-1.9)
-
This Week's Activated Carbon Prices Rise in China (1.5-1.9)
-
TBHQ: Uses, Safety, and Health Effects
-
MTBE Market Prices Fluctuate and Decline